Fri 8/17/2018 10:46 ET
DJIA25326.167.660.03%TELCO168.920.740.44%GOLD1185.801.780.15%Shanghai2694.5210.510.39%
S&P 5002835.325.390.19%BANKS486.650.050.01%OIL65.840.380.58%BITCOIN6484.47164.712.54%
NASDAQ7758.7647.330.61%PHARM563.831.470.26%US/EU1.170.000.26%Futures2830.7523.000.81%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - International Stem Cell Corporation - ISCO.OB   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ISCO.OB
  
From: QualityStocks (Rep: 4)Date: 06/11/2013 12:09
Forum: International Stem Cell Corporation - Msg #119Thread #673535885 (Rec: 0)
International Stem Cell Corp. (ISCO) Extends Market Reach in Asia through Strategic Distribution Agreements

International Stem Cell, a biotech company developing novel stem cell-based therapies and skin care products, reports that its operating subsidiary, Lifeline Skin Care, has entered into distribution agreements to market its stem cell skin care products in Thailand and Viet Nam beginning this summer.

Per the agreement, My Son IEI will distribute Lifeline products in Viet Nam. My Son distributes to hospitals, pharmacies, and other retail locations and is the only company licensed to develop and market therapeutic stem cell products in Viet Nam. In addition to distributing the skin care products, ISCO and My Son are discussing avenues through which to leverage ISCO’s patented parthenogenetic stem cell technology to develop new and innovative therapies for Vietnamese consumers.

Thai distributor Advanced Skincare Technologies will market Lifeline Skin Care to physicians, spas, hospitals, and pharmacies in Thailand. The president of Advanced Skincare Technologies has an established presence in the market, having founded the first company in Asia to apply stem cell therapy to commercially treat patients suffering from cardiomyopathy, and is now focused on offering cosmetic stem cell treatments.

The distribution agreement is complementary to Lifeline’s existing distribution relationship in China and support Lifeline’s goal to capitalize on opportunities in the Asian market.

“We’re excited to have such strong and reputable partners that can quickly leverage their experience and resources to our mutual advantage,” Simon Craw, PhD, executive vice president of ISCO stated in the press release. “Asia is poised for huge sales growth in cosmetics in the next five years. According to Euromonitor, sales of cosmetics and toiletries in the Asia Pacific region is expected to surge 26 percent, compared to only 3.5 percent in North America. We’re pleased to be on the forefront of stem cell skincare in Asia.”

For additional information, visit www.InternationalStemCell.com

Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser QualityStocks: Reward | Watch | IgnoreISCO.OB: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ISCO.OB
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.